| Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications S Rani, AE Ryan, MD Griffin, T Ritter Molecular Therapy 23 (5), 812-823, 2015 | 1078 | 2015 |
| MiRNA biogenesis and regulation of diseases: an overview A Vishnoi, S Rani MicroRNA profiling: Methods and protocols, 1-10, 2017 | 700 | 2017 |
| Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes C Corcoran, S Rani, K O’Brien, A O’Neill, M Prencipe, R Sheikh, G Webb, ... PloS one 7 (12), e50999, 2012 | 498 | 2012 |
| The exosome‐A naturally secreted nanoparticle and its application to wound healing S Rani, T Ritter Advanced materials 28 (27), 5542-5552, 2016 | 264 | 2016 |
| miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity K O'Brien, MC Lowry, C Corcoran, VG Martinez, M Daly, S Rani, ... Oncotarget 6 (32), 32774, 2015 | 251 | 2015 |
| Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells K O’Brien, S Rani, C Corcoran, R Wallace, L Hughes, AM Friel, ... European journal of cancer 49 (8), 1845-1859, 2013 | 249 | 2013 |
| miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression C Corcoran, S Rani, L O'Driscoll The Prostate 74 (13), 1320-1334, 2014 | 237 | 2014 |
| Characterisation and manipulation of docetaxel resistant prostate cancer cell lines AJ O'Neill, M Prencipe, C Dowling, Y Fan, L Mulrane, WM Gallagher, ... Molecular cancer 10, 1-13, 2011 | 224 | 2011 |
| Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells K Kumar Jella, S Rani, L O'driscoll, B McClean, HJ Byrne, FM Lyng Radiation research 181 (2), 138-145, 2014 | 179 | 2014 |
| Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling S Rani, K O’Brien, FC Kelleher, C Corcoran, S Germano, MW Radomski, ... Gene Expression Profiling: Methods and Protocols, 181-195, 2011 | 130 | 2011 |
| Phenotypic and global gene expression profile changes between low passage and high passage MIN-6 cells L O’Driscoll, P Gammell, E McKiernan, E Ryan, PB Jeppesen, S Rani, ... Journal of endocrinology 191 (3), 665-676, 2006 | 106 | 2006 |
| Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma S Rani, K Gately, J Crown, K O’Byrne, L O’Driscoll Cancer biology & therapy 14 (12), 1104-1112, 2013 | 95 | 2013 |
| miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer C Corcoran, S Rani, S Breslin, M Gogarty, IM Ghobrial, J Crown, ... Molecular cancer 13, 1-12, 2014 | 89 | 2014 |
| Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? G O'Malley, M Heijltjes, AM Houston, S Rani, T Ritter, LJ Egan, AE Ryan Oncotarget 7 (37), 60752, 2016 | 65 | 2016 |
| Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines A Pierce, PM McGowan, M Cotter, M Mullooly, N O’Donovan, S Rani, ... Cancer biology & therapy 14 (6), 537-545, 2013 | 55 | 2013 |
| Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors S Rani, C Corcoran, L Shiels, S Germano, S Breslin, S Madden, ... Cancer research 74 (14), 3821-3833, 2014 | 53 | 2014 |
| Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives LE León, S Rani, M Fernandez, M Larico, SD Calligaris Journal of diabetes research 2016 (1), 6143129, 2016 | 52 | 2016 |
| miRNA biogenesis and regulation of diseases: an updated overview A Vishnoi, S Rani MicroRNA Profiling: Methods and Protocols, 1-12, 2022 | 50 | 2022 |
| Chitosan-coated PLGA nanoparticles encapsulating triamcinolone acetonide as a potential candidate for sustained ocular drug delivery M Dandamudi, P McLoughlin, G Behl, S Rani, L Coffey, A Chauhan, ... Pharmaceutics 13 (10), 1590, 2021 | 45 | 2021 |
| Decreasing Txnip mRNA and protein levels in pancreatic MIN6 cells reduces reactive oxygen species and restores glucose regulated insulin secretion S Rani, JP Mehta, N Barron, P Doolan, PB Jeppesen, M Clynes, ... Cellular physiology and biochemistry 25 (6), 667-674, 2006 | 42 | 2006 |
Claire CorcoranSenior Scientist, AstraZeneca在 tcd.ie 的电子邮件经过验证
